Efficacy of early immunosuppressive therapy in a child with carbamazepine-associated vanishing bile duct and Stevens-Johnson syndromes.
Garcia
Monica
M
Department of Pediatrics, Case Western Reserve University, MetroHealth Medical Center, Cleveland, Ohio 44109, USA.
Mhanna
Maroun J
MJ
Chung-Park
Moon-Ja
MJ
Davis
Pamela H
PH
Srivastava
Maya D
MD
D001649:Bile Duct Diseases / Q000139:chemically induced* / Q000188:drug therapy*; D001653:Bile Ducts, Intrahepatic / Q000473:pathology*; D002220:Carbamazepine / Q000009:adverse effects*; D002675:Child, Preschool; D002779:Cholestasis / Q000150:complications; D006509:Hepatitis B / Q000150:complications; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D010195:Pancreatitis / Q000150:complications; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced* / Q000188:drug therapy*; D016559:Tacrolimus / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D002220:Carbamazepine; D016559:Tacrolimus; D008775:Methylprednisolone